Low-dose dopamine in the intensive care unit

Seminars in Dialysis

Volumn 19, Issue 6, 2006, Pages 465-471

  Karthik, Swaminathan ^a   Lisbon, Alan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIURESIS; DOSE RESPONSE; DRUG EFFECT; GASTROINTESTINAL TRACT; HEART ARRHYTHMIA; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; ISCHEMIA; KIDNEY; METABOLISM; MORTALITY; PATHOPHYSIOLOGY; SEPSIS; VASCULARIZATION;

ANOXEMIA; ARRHYTHMIA; CLINICAL TRIALS; DIURESIS; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL TRACT; HUMANS; INTENSIVE CARE UNITS; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; SEPSIS;

EID: 33750943339     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00208.x     Document Type: Article

References (54)

1. Hoffman BB. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed:226-227
2. Horwitz D, Fox SM, Goldberg LI: Effects of dopamine in man. Circ Res 10:237-243, 1962
3. McDonald RH Jr, Goldberg LI, McNay JL, Turtle EP: Effects of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 43:1116-1124, 1964
4. McNay JL, McDonald RH Jr, Goldberg LI: Direct renal vasodilatation produced by dopamine in the dog. Circ Res XVI:510-517, 1965
5. Corwin HL, Lisbon A: Renal dose dopamine: Long on conjecture, short on fact. Crit Care Med 28:1657-1658, 2000
6. Thompson BT, Cockrill BA: Renal-dose dopamine: A siren song? Lancet 344:7-8, 1994
7. Goldberg LI, McDonald RH Jr, Zimmerman AM: Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med 269:1060-1064, 1963
8. Goldberg LI: Dopamine - Clinical uses of an endogenous catecholamine. N Engl J Med 291:707-710, 1974
9. Stoof JC, Kebabian SW: Two dopamine receptors: Biochemistry, physiology, and pharmacology. Life Sci 35:2281, 1984
10. Missale C, Nash SR, Robinson SW, Jaber M, Carch MG: Dopamine receptors: From structure to function. Physiol Rev 78:189-225, 1998
11. Goldberg LI, Rajfer SI: Dopamine receptors: Applications in clinical cardiology. Circulation 72:245-248, 1985
12. D'Orio V, Allaf D, Juchmes J, Marcelle R: The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 92:S11-S20, 1984
13. Ratge D, Steegmuller U, Mikus G, Kohse KP, Wisser H: Dopamine infusion in healthy subjects and critically ill patients. Clin Exp Pharmacol Physiol 17:361-369, 1990
14. Juste RN, Moran L, Hooper J, Soni N: Dopamine clearance in critically ill patients. Intensive Care Med 24:1217-1220, 1998
15. Jarnberg PO, Bengstoon L, Ekstrand J, Hamberger B: Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics. Acta Anaesthesiol Scand 25:328-331, 1981
16. MacGregor DA, Smith TE, Prielipp RC, Butterworth JF, James RL, Scuderi PE: Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 92:338, 2000
17. Bailey JM, James M: Dopamine: One size does not fit all. Anesthesiology 92:303, 2000
18. Lumlertgul D, Keoplung M, Sitprija V, Moolloar P, Suwangool P: Furosemide and dopamine in malarial acute renal failure. Nephron 52:40-44, 1989
19. De La Cal MA, Miravelles E, Pascual T, Esteban A, Ruiz-Santana S: Dose-related hemodynamic and renal effects of dopamine in septic shock. Crit Care Med 12:22-25, 1984
20. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Anderson N, Leyssal PP: Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin Sci (Lond) 78:503-507, 1990
21. Hoogenberg, K, Smit, AJ, Girbes ARJ: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 26:260-265, 1998
22. Schaer GL: Norepinephrine plus low-dose dopamine: A beneficial combination. Crit Care Med 2:205, 1998
23. Dalton RS, Webber JN, Cameron C, Ressaris N, Gibb PG, Tan LC, Walters MA, Saoek SA, Datta AK: Physiologic impact of low-dose dopamine on renal function in the early post renal transplant period. Transplantation 79:1561-1567, 2005
24. Swygert T, Roberts L, Valek T, Brajtbord D, Brown MR, Gunning TL, Paulson AW, Ramsay MA: Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 75:571-576, 1991
25. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744-747, 1994
26. Lema G, Urzua J, Jalil R, Canessa R, Moran S, Sallo C, Medel J, Irarrazaval M, Zalaquett R, Fajardo C, Meneses G: Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function. Anesth Analg 86:3-8, 1998
27. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effect of dopamine during cardiac surgery. J Am Soc Nephrol 11:97-104, 2000
28. Ichai C, Passeron C, Carles M, Bouregba M, Grimaud D: Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: A singleblind, prospective, controlled study. Crit Care Med 28:1329-1335, 2000
29. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM: Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 101:49-53, 1996
30. Marik PE, Iglesias J: Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators. Am J Med 107:387-390, 1999
31. Kellum JA, Decker JM: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29:1526-1531, 2001
32. Marik P: Low-dose dopamine: a systematic review. Intensive Care Med 28:877-883, 2002
33. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J: Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial: Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139-2143, 2000
34. Friedrich JO, Adhikari N, Herridge MS, Beyene J: Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142:510-524, 2005
35. Rosen S, Epstein FH, Brezis M: Determinants of intrarenal oxygenation: Factors in acute renal failure. Ren Fail 14:321-325, 1992. Review
36. Brezis M, Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 332:647-655, 1995
37. Brezis M, Agmon Y, Epstein FH: Determinants of intrarenal oxygenation. 1. Effects of diuretics. Am J Physiol 267:F1059-F1062, 1994
38. Brezis M, Heyman SN, Epstein FH: Determinants of intrarenal oxygenation. 2. Hemodynamic effects. Am J Physiol 267:F1063-F1068, 1994
39. Lisbon A: Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: What is the evidence? Chest 123(5 Suppl):460S-463S, 2003
40. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischaemia in a porcine model of hemorrhagic shock. J Appl Physiol 73:1159-1164, 1992
41. Marik PE, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354-1357, 1994
42. Jakob SM, Ruokonen E, Takala J: Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18:8-13, 2002
43. Johnson RL Jr: Low-dose dopamine and oxygen transport by the lung. Circulation 98:97-99, 1998
44. Welsh MJ, Heistad DD, Abboud FM: Depression of ventilation by dopamine in man: Evidence for an effect on the chemoreceptor reflex. J Clin Invest 61:708-713, 1978
45. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier HD, Ocampo HA: Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 96:120-126, 1989
46. Van de Borne P, Oren R, Virend KS: Dopamine depresses minute ventilation in patients with heart failure. Circulation 98:126-131, 1998
47. Van den Berghe G, Zegher F: Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24:1580-1590, 1996
48. Van den Berghe G, de Zegher F, Lauwers P: Growth hormone secretion in critical illness: Effect of dopamine. J Clin Endocrinol Metab 79:1141-1146, 1994
49. Van den Berghe G, de Zegher F, Lauwers P: Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol 41:731-737, 1994
50. Devins SS, Miller A, Herndon BL, O'toole L, Reisz G: Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 263:9682-9685, 1992
51. Argalious M, Motta P, Khandwala F, Samuel S, Koch CG, Gillinov AM, Yared JP, Starr NJ, Bashour CA: 'Renal dose' dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med 33:1327-1332, 2005
52. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34:589-597, 2006
53. Brienza N, Malcangi V, Dalfino L, Trerotou P, Guagliardi L, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T: A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34:707-714, 2006
54. Holmes CL: Is low-dose vasopressin the new reno-protective agent? Crit Care Med 32:1972-1974, 2004